PharosAI, a UK cancer AI consortium, has received Innovate UK funding for a project called DESTINY that asks whether AI…
AbbVie, argenx, Lundbeck and Takeda are contributing proprietary antibody sequences to a shared dataset aimed at predicting which drug candidates…
Owkin and AstraZeneca are expanding their AI collaboration to develop new drug discovery models using federated learning, a technique that…